Home MRK
  Price1.06%   +1.09
(After Hours: 104.01 -0.02 -0.02% )

Merck & Company (new) (MRK) Latest News

Feb-06-23 01:41AM Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is DownBenzinga
Feb-03-23 09:19AM Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc LawsuitsZacks Investment Research
Feb-02-23 03:38AM S&P 500, Nasdaq surge to about five-month highs as Meta leads rally in tech sector stocksMarketWatch
02:30AM Merck (MRK) Q4 2022 Earnings Call TranscriptThe Motley Fool
Feb-02-23 02:25AM Nasdaq surges to five-month high as Meta leads rally in tech sectorMarketWatch
11:54AM U.S. stocks surge to five-month highs as Meta earnings push Nasdaq into the leadMarketWatch
Feb-02-23 11:11AM Why These 2 Stocks Made the Dow Miss the Market RallyThe Motley Fool
11:04AM Economic Data DelugeZacks Investment Research
Feb-02-23 10:53AM Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View DisappointsZacks Investment Research
10:39AM Goldilocks Econ Data Presides Over Pre-MarketZacks Investment Research
Feb-02-23 10:27AM U.S. stocks open higher as Nasdaq surges on Meta earnings, Powell remarks; Dow sinksMarketWatch
09:10AM U.S. stocks set to open higher after Meta results, Powell press conferenceMarketWatch
Feb-02-23 07:55AM Merck (MRK) Beats Q4 Earnings and Revenue EstimatesZacks Investment Research
07:54AM There's still too much risk in stock and bond markets. Earn this easy 4.5% return while you wait for stability, says trader who hit 2 big calls in 2022.MarketWatch
Feb-02-23 07:17AM Wall Street Breakfast Podcast: META RocketsSeeking Alpha
06:35AM Got $5,000? 3 Stocks to Hold for the Next 20 YearsThe Motley Fool
Feb-02-23 06:34AM Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?Benzinga
Feb-01-23 10:44AM Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & OthersZacks Investment Research
09:18AM Will Keytruda & Gardasil Aid Merck (MRK) Sales in Q4 Earnings?Zacks Investment Research
Feb-01-23 08:46AM Why Merck & Co. (MRK) Might Surprise This Earnings SeasonZacks Investment Research
08:30AM 3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023The Motley Fool
Jan-30-23 04:00AM Down 14.5%, Is Pfizer Stock a Screaming Buy?The Motley Fool
08:05AM Merck (MRK) to Report Q4 Earnings: What's in the Cards?Zacks Investment Research
Jan-27-23 10:07AM Will This Billion-Dollar Acquisition Be a Smart Move for Merck?The Motley Fool
08:14AM Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study EndsZacks Investment Research
Jan-26-23 10:01AM Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research
09:53AM 2 Market-Beating Stocks to Buy in 2023 and Hold for 10 YearsThe Motley Fool
Jan-26-23 07:39AM How I'd Invest $50,000 for Retirement If I Had to Start From ScratchThe Motley Fool
07:17AM Earn Dividends Every Month With These 3 StocksThe Motley Fool
Jan-25-23 08:59AM Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?Zacks Investment Research
06:20AM Should Invesco Dynamic Large Cap Value ETF (PWV) Be on Your Investing Radar?Zacks Investment Research
Jan-25-23 05:25AM Want to Collect a Dividend Every Month? Buy These 3 High-Yielding StocksThe Motley Fool
Jan-24-23 12:15PM Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6%Zacks Investment Research
06:20AM Is Nuveen ESG LargeCap Value ETF (NULV) a Strong ETF Right Now?Zacks Investment Research
Jan-23-23 03:01AM Where Merck & Co Stands With AnalystsBenzinga
08:50AM How to Boost Your Portfolio with Top Medical Stocks Set to Beat EarningsZacks Investment Research
Jan-23-23 06:20AM Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?Zacks Investment Research
Jan-20-23 08:50AM How to Find Strong Medical Stocks Slated for Positive Earnings SurprisesZacks Investment Research
08:05AM J&J (JNJ) to Begin Q4 Earnings Season for Pharma SectorZacks Investment Research
Jan-20-23 08:04AM Zacks Market Edge Highlights: Bank of America, Microsoft, Chevron, Merck and Marathon DigitalZacks Investment Research
Jan-19-23 02:10AM Advice for Long-Term Stock InvestorsZacks Investment Research
10:26AM Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study GoalZacks Investment Research
Jan-17-23 11:21AM Corcept (CORT) Rides on Robust Korlym Sales, High Reliance a WoeZacks Investment Research
09:00AM Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research
Jan-17-23 06:20AM Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?Zacks Investment Research
06:20AM Is Invesco Dynamic Large Cap Value ETF (PWV) a Strong ETF Right Now?Zacks Investment Research
Jan-13-23 06:20AM Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?Zacks Investment Research
Jan-12-23 06:20AM Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?Zacks Investment Research
Jan-11-23 09:23AM FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian's Executive Departures: Today's Top StoriesBenzinga
05:00AM The Zacks Analyst Blog Highlights Home Depot, Merck, Bank of America, Elevance Health and ResMedZacks Investment Research
Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic and preventive agents to treat cardiovascular diseases, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases. It also provides neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors, and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. The company also provides companion animal products, such as ointments; diabetes mellitus; anthelmintic products; fluralaner products to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. Merck & Co., Inc. has collaborations with Pfizer Inc., AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., IO Biotech, Premier Inc., Cue Biopharma, Inc., Foundation Medicine, Inc., Daiichi Sankyo Company, Limited, and Cold Genesys, Inc. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Cap:    |  Volume (24h):